Dr. Jianhua Zou, National University of Singapore, Singapore.
Dr. Jianhua Zou 👨⚕️ is a passionate biomedical researcher at the Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore 🇸🇬. He specializes in photo-immunotherapy, nanomedicine, and cancer vaccine technologies 🎯🧫. With over S$23 million in collaborative and principal investigator-led projects 💰, he leads innovative research into personalized treatment solutions. His expertise spans tumor-targeted therapies, mRNA delivery, and immune system enhancement 🧠💉. Dr. Zou is also recognized internationally for his contributions, having been an invited speaker at NIH, USA 🌍🎤, and celebrated for impactful essays and scientific leadership 🏅📚.
Publication Profiles
Education & Experience
🎓 Education
-
🧪 Ph.D. in Chemistry
📍 Nanjing Tech University, China (2015.09–2020.06)
👨🏫 Supervisor: Prof. Wei Huang (Academician of Chinese Academy of Sciences)
-
🧫 Bachelor of Chemistry
📍 Changshu Institute of Technology, China (2011.09–2015.06)
👩🏫 Supervisor: Prof. Qiaoyun Li
💼 Professional Experience
-
🧬 Research Fellow
📍 National University of Singapore, Singapore (2021.03–Present)
👨🏫 Supervisor: Prof. Xiaoyuan Chen
-
🧫 Postdoctoral Fellow
📍 National Institutes of Health (NIH), USA (2020.07–2021.02)
👨⚕️ Supervisor: Dr. Richard Leapman (Director of NIBIB)
-
🔬 Visiting Scholar
📍 National Institutes of Health (NIH), USA (2018.11–2020.06)
👨🏫 Supervisor: Dr. Xiaoyuan Chen
Summary Suitability For The Award
Dr. Jianhua Zou, a highly accomplished biomedical researcher based in Singapore, is a prime candidate for the Best Review Paper Award, owing to his extensive scholarly background, deep expertise in cancer immunotherapy, and ongoing contribution to high-impact review publications in nanomedicine and biotherapeutics. His multidisciplinary training, international research exposure, and active involvement in cutting-edge biomedical innovation provide a strong foundation for authoring insightful and transformative review articles.
Professional Development
Dr. Jianhua Zou’s professional journey is marked by high-level interdisciplinary collaboration and innovation 🌐🔬. He serves as Principal Investigator and collaborator on various national-level research projects funded by Singapore’s Ministry of Health and National Research Foundation 💼💡. His leadership in developing next-generation photosensitizers and therapeutic nanovaccines demonstrates his commitment to precision medicine 🎯💊. Dr. Zou actively engages with the global scientific community through prestigious speaking invitations and research alliances 🤝🌎. His ongoing contributions are not only transforming cancer therapy but also enhancing immune-based interventions for broader clinical applications 🛡️🧪.
Research Focus
Dr. Jianhua Zou’s research lies at the intersection of cancer immunotherapy, nanomedicine, and molecular diagnostics 🧬🧫. His work focuses on engineering type I photosensitizers, mRNA-based nanocarriers, and targeted nanovaccines to enhance immune responses against complex diseases such as cancer and atherosclerosis 💉🦠. Projects under his guidance explore innovative platforms like oral nanodrugs for microbiota modulation and site-specific delivery systems for tumors 🎯⚙️. With a vision toward personalized medicine, his research brings together the latest in biomedical engineering, oncology, and pharmacology to design effective, non-invasive therapeutic strategies 🌟🔬.
Publication Top Noted
-
📄 Surface Modified Ti3C2 MXene Nanosheets for Tumor Targeting Photothermal/Photodynamic/Chemo Synergistic Therapy — 630 citations, 2017
-
💡 BODIPY derivatives for photodynamic therapy: influence of configuration versus heavy atom effect — 254 citations, 2017
-
🧬 Solvent-assisted self-assembly of a metal–organic framework based biocatalyst for cascade reaction driven photodynamic therapy — 240 citations, 2020
-
🔬 Black phosphorus nanosheets immobilizing Ce6 for imaging-guided photothermal/photodynamic cancer therapy — 232 citations, 2018
-
🧪 In situ polymerized hollow mesoporous organosilica biocatalysis nanoreactor for enhancing ROS‐mediated anticancer therapy — 192 citations, 2020
-
🌌 A phototheranostic strategy to continuously deliver singlet oxygen in the dark and hypoxic tumor microenvironment — 181 citations, 2020
-
🌟 Photosensitizer synergistic effects: D–A–D structured organic molecule with enhanced fluorescence and singlet oxygen quantum yield for photodynamic therapy — 155 citations, 2018
-
🔥 Penetration depth tunable BODIPY derivatives for pH triggered enhanced photothermal/photodynamic synergistic therapy — 148 citations, 2019